BCL2L11 |
---|
|
Strwythurau |
---|
PDB | Human UniProt search: PDBe RCSB |
---|
Rhestr o ddynodwyr PDB |
---|
1F95, 2K7W, 2NL9, 2V6Q, 2VM6, 2WH6, 2YQ6, 2YQ7, 3D7V, 3FDL, 3IO8, 3IO9, 3KJ0, 3KJ1, 3KJ2, 4A1U, 4A1W, 4B4S, 4D2M, 4QVF, 4UF3, 4YJ4, 4ZIF, 4ZIH, 5AGW, 5AGX, 5C3G |
|
|
Dynodwyr |
---|
Cyfenwau | BCL2L11, BAM, BIM, BOD, BCL2 like 11 |
---|
Dynodwyr allanol | OMIM: 603827 HomoloGene: 7643 GeneCards: BCL2L11 |
---|
|
|
Orthologau |
---|
Species | Bod dynol | Llygoden |
---|
Entrez | | |
---|
Ensembl | | |
---|
UniProt | | |
---|
RefSeq (mRNA) | | |
---|
RefSeq (protein) | | |
---|
Lleoliad (UCSC) | n/a | n/a |
---|
PubMed search | [1] | n/a |
---|
Wicidata |
|
Protein sy'n cael ei godio yn y corff dynol gan y genyn BCL2L11 yw BCL2L11 a elwir hefyd yn Bcl-2-like protein 11 a BCL2 like 11 (Saesneg). Segment o DNA yw'r genyn, sy'n amgodio ffwythiant arbennig. Mae'r genyn yma wedi ei leoli ar yr edefyn blaen o gromosom dynol 2, band 2q13.[2]
Yn aml mae gan enynnau lawer o gyfystyron. Mae hyn oherwydd eu bod yn aml yn cael eu darganfod gan nifer o bobl mewn cyd-destunau gwahanol heb wybod mai'r un genynnau oeddyn nhw. Hefyd mae gan wahanol gymunedau gwyddonol safonau gwahanol ar gyfer enwi genynnau. Dyma restr o gyfystyron ar gyfer y genyn BCL2L11.
- "BIM deletion polymorphisms in Hispanic patients with non-small cell lung cancer carriers of EGFR mutations. ". Oncotarget. 2016. PMID 27926478.
- "CD4+ T cells from patients with primary sclerosing cholangitis exhibit reduced apoptosis and down-regulation of proapoptotic Bim in peripheral blood. ". J Leukoc Biol. 2017. PMID 27630216.
- "Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer. ". Anticancer Res. 2017. PMID 28870908.
- "Lack of association between deletion polymorphism of BIM gene and in vitro drug sensitivity in B-cell precursor acute lymphoblastic leukemia. ". Leuk Res. 2017. PMID 28641145.
- "Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancer.". Cancer. 2017. PMID 28346673.